# 108 Biocapital Growth Fund, LP 108 Biocapital Growth Fund, LP is a Venture Capital Growth Fund based in Danbury, United States. ## Overview - **Organization type:** Venture Capital Growth Fund - **Headquarters:** Danbury, United States - **Region:** North America - **Address:** San Francisco, CA, United States - **Founded:** 2020 - **Assets under management:** Undisclosed (Altss estimate) ## Regulatory record - **CRD number:** 339648 - **SEC file number:** 802-135191 - **Registration status:** Registered - **Reports private funds:** Yes - **IAPD record:** https://adviserinfo.sec.gov/firm/summary/339648 ## About 108 BioCapital Growth Fund, LP is an exempt reporting adviser in Danbury, CT. It advises the 108 BioCapital Growth Fund, LP. The fund focuses on life sciences and healthcare investments. ## Sectors - Life Sciences - Biotech ## Questions ### What therapeutic areas does 108 Biocapital Growth Fund prioritize? The fund invests across multiple therapeutic areas including oncology, neurology, and rare diseases. It backs companies developing small molecules, biologics, and cell/gene therapies. ### How does 108 Biocapital Growth Fund source its deal flow? The fund sources deals through relationships with research institutions, licensing partners, and co-investment relationships with larger life sciences venture firms. Public disclosures are limited. ### What is 108 Biocapital Growth Fund's geographic focus? The fund concentrates on North America, primarily the United States. Its portfolio companies are largely located in major biotech hubs including the San Francisco Bay Area, Boston, and San Diego. ## Related profiles - [Great Valley Tax & Financial Services](https://altss.com/profile/great-valley-tax-and-financial-services) - [CENTRUS FINANCIAL STRATEGIES](https://altss.com/profile/centrus-financial-strategies) --- Last updated: 2026-08-14T12:30:00.000Z Canonical page: https://altss.com/profile/108-biocapital-growth-fund-lp Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology